A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

NCT07454720 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Resectable Rectal Cancer

Interventions

DRUG: Adebrelimab in combination with SHR-8068 and chemotherapy
DRUG: Adebrelimab combined with chemotherapy
DRUG: Chemotherapy

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.